METTL3 and neoplasm: METTL3 was shown to be involved in tumour progression, such as promoting the progression of colon cancer through tumour immunosuppression [21], mediating acetylation to promote the progression of breast cancer [22], and regulating the m6A modification level of mRNA to facilitate the progression of bladder cancer [23].